Toll Free: 1-888-928-9744

Head And Neck Cancer Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 1597 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Head And Neck Cancer Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Head And Neck Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Head And Neck Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Head And Neck Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Head And Neck Cancer to Oncology Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Head And Neck Cancer to Oncology Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Head And Neck Cancer Therapeutics Clinical Trials 27 Prominent Drugs 28 Latest Clinical Trials News on Head And Neck Cancer 29 May 19, 2016: Bayer to Showcase Latest data on Nexavar (sorafenib) at ASCO 2016 29 May 16, 2016: New KEYTRUDA (pembrolizumab) Data at 2016 ASCO Annual Meeting Includes Three-Year Overall Survival Data in Melanoma and Updated Overall Survival Data in Non-Small Cell Lung Cancer As Well As Updated Findings in Head and Neck Cancer 29 May 16, 2016: Fate Therapeutics Announces Preclinical Data Highlighting Persistent Effector Function of Allogeneic Natural Killer Cell Cancer Immunotherapy 30 May 02, 2016: CEL-SCI Reports Record Monthly Patient Enrollment in April for Its Phase 3 Head and Neck Cancer Trial 31 Apr 26, 2016: NIHR Cancer study has Groundbreaking results 32 Apr 20, 2016: Celldex Therapeutics Presents Data Supporting the Clinical Development of Glembatumumab Vedotin at the AACR Annual Meeting 2016 32 Apr 18, 2016: AstraZeneca Presents Data on Next-generation Investigational Wee1 Inhibitor at the AACR 2016 Annual Meeting 33 Apr 01, 2016: CEL-SCI Reports Monthly Patient Enrollment in March for Its Phase 3 Head and Neck Cancer Trial 33 Mar 29, 2016: Inovio Updates INO-3112 HPV Immunotherapy Development Plan 34 Mar 29, 2016: Advaxis Combination Trial with MedImmune Completes First Dose-Escalation Cohort 34 Mar 17, 2016: Celldex Therapeutics to Present New Clinical and Preclinical Data at the AACR Annual Meeting 2016 35 Mar 02, 2016: Advaxis Study in Head and Neck Cancer Selected for Late-Breaking Poster at the American Association for Cancer Research Annual Meeting 35 Mar 01, 2016: CEL-SCI Reports Monthly Patient Enrollment in February for Its Phase 3 Head and Neck Cancer Trial 36 Clinical Trial Profile Snapshots 37 Appendix 1594 Abbreviations 1594 Definitions 1594 Research Methodology 1595 Secondary Research 1595 About GlobalData 1596 Contact Us 1596 Disclaimer 1596 Source 1597
List of Tables
Head And Neck Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 6 Head And Neck Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Head And Neck Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Head And Neck Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Head And Neck Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Head And Neck Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Head And Neck Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Head And Neck Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of Head And Neck Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Head And Neck Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Head And Neck Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Head And Neck Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Head And Neck Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Head And Neck Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Head And Neck Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Head And Neck Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Head And Neck Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Head And Neck Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Head And Neck Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Head And Neck Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Head And Neck Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Head And Neck Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Head And Neck Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28


List of Figures
Head And Neck Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Head And Neck Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Head And Neck Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Head And Neck Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Head And Neck Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Head And Neck Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Head And Neck Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Head And Neck Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of Head And Neck Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Head And Neck Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Head And Neck Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Head And Neck Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Head And Neck Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Head And Neck Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Head And Neck Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Head And Neck Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Head And Neck Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Head And Neck Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Head And Neck Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Head And Neck Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Head And Neck Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Head And Neck Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Head And Neck Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 1595

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify